RCE in Draytek Vigor167
CVE-2023-47254
An OS Command Injection in the CLI interface on DrayTek Vigor167 version 5.2.2, allows remote attackers to execute arbitrary system commands and escalate privileges via any account created within the web interface.
Vulnerability class: Command Injection (OS Command Injection)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.022 (81.8th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 82nd percentile — 81.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.022 · newest: 0.022 · change: 0.000
Affected products
- Draytek Vigor167
- Draytek Vigor167 Firmware — versions 5.2.2
Weakness classification (CWE)
Public proof-of-concept exploits
References
- www.syss.de/fileadmin/dokumente/Publikationen/Advisories/SYSS-2023-023.txt (Exploit, Third Party Advisory)
- www.syss.de/pentest-blog/command-injection-via-cli-des-draytek-vigor167-syss-20… (Third Party Advisory)
Frequently asked questions
- What is CVE-2023-47254?
- CVE-2023-47254 is a critical-severity vulnerability in Draytek Vigor167, classified under OS Command Injection. CVSS score: 9.8/10. Published 2023-12-09.
- How severe is CVE-2023-47254?
- Critical severity. CVSS v3 base score is 9.8 out of 10.
- Is CVE-2023-47254 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.